PDS BIOTECHNOLOGY CORP's ticker is PDSB and the CUSIP is 70465T107. A total of 31 filers reported holding PDS BIOTECHNOLOGY CORP in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $76,875 | -53.4% | 25,000 | +100.0% | 0.04% | -56.7% |
| Q4 2022 | $165,000 | +123.0% | 12,500 | -50.0% | 0.09% | +246.2% |
| Q3 2022 | $74,000 | +60.9% | 25,000 | +100.0% | 0.03% | -10.3% |
| Q2 2022 | $46,000 | -40.3% | 12,500 | 0.0% | 0.03% | -31.0% |
| Q1 2022 | $77,000 | -69.0% | 12,500 | -24.9% | 0.04% | -68.9% |
| Q3 2021 | $248,000 | -40.7% | 16,655 | -50.0% | 0.14% | +7.1% |
| Q2 2021 | $418,000 | +175.0% | 33,310 | 0.0% | 0.13% | +152.0% |
| Q1 2021 | $152,000 | +322.2% | 33,310 | +100.0% | 0.05% | +108.3% |
| Q4 2020 | $36,000 | -53.8% | 16,655 | -50.0% | 0.02% | -25.0% |
| Q3 2020 | $78,000 | +136.4% | 33,310 | +100.0% | 0.03% | +10.3% |
| Q2 2020 | $33,000 | +175.0% | 16,655 | 0.0% | 0.03% | +123.1% |
| Q1 2020 | $12,000 | -72.7% | 16,655 | 0.0% | 0.01% | -65.8% |
| Q4 2019 | $44,000 | – | 16,655 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INSPIRION WEALTH ADVISORS, LLC | 330,874 | $1,670,914 | 0.33% |
| TANG CAPITAL MANAGEMENT LLC | 400,000 | $2,020,000 | 0.28% |
| AMUSSEN HUNSAKER ASSOCIATES LLC | 75,016 | $377,330 | 0.08% |
| Nebula Research & Development LLC | 25,708 | $129,825 | 0.07% |
| Corton Capital Inc. | 22,091 | $111,560 | 0.06% |
| Sofinnova Investments, Inc. | 142,635 | $720,307 | 0.04% |
| LAZARI CAPITAL MANAGEMENT, INC. | 11,000 | $55,550 | 0.03% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 24,369 | $123,063 | 0.02% |
| WINTON GROUP Ltd | 21,256 | $107,343 | 0.01% |
| Truvestments Capital LLC | 1,372 | $6,929 | 0.00% |